Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 689

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 689
---
HURA Common Stock at an estimated price of the TuHURA10-dayVWAP as of the date each investor subscribes to the Concurrent Investment, approximately $4.0383 per share (based on the VWAP as of April 30, 2025).To-date,while TuHURA has not currently executed any subscription agreement in connection with this contemplated Concurrent Investment, this pro forma adjustment is reflected in the unaudited pro forma condensed combined financial information as contemplated since it is a condition precedent to the closing of the Mergers.DReflects the actual and assumed exercises of outstanding TuHURA warrants and Penny Warrants subsequent to December 31, 2024 for a total underlying of 1,653,666 shares issued (consisting of 1,356,637 and 297,029 warrants exercised, respectively). While the subsequent exercises are not directly attributable to the closing of the Mergers, since the subsequent issuance of shares of TuHURA Common Stock directly impacts the share capitalization of the combined company on a pro forma basis, a pro forma adjustment of 1,653 is presented to recognize the shares of TuHURA Common Stock issued at par value and give pro forma effect to the Mergers as if all the related transactions occurred on December 31, 2024.TuHURA initially recorded a Warrant Note Receivable of $3,057,904 for the value of the warrants, including interest, that the holders of the warrants issued in lieu of payment upon exercise. Based on the terms and provisions of these notes, the entire amount is expected to be received prior to the Closing Date of the Mergers and accordingly a $3,562,115 adjustment to reflect the increase in cash for TuHURA upon the receipt of cash for these exercises is presented (consisting of the $3,057,904 notes to be realized before the Closing plus the $504,211 already received). Additionally, as described in Note 1 in the notes to the unaudited pro forma condensed combined financial information, the Penny Warrants are effectivelypre-funded,resulting in nominal additional cash for TuHURA upon exercise, and the net zero impact to Additionalpaid-incapital is already reflected within TuHURA’s historical financial statements as of December 31, 2024. Accordingly, as the Penny Warrants are assumed to be exercised to give pro forma effect to the Kintara Mergers, the Mergers and all related transactions, the net amount of the cash received for